Cognitive impairment associated with increased mortality rate in patients with heart failure: A systematic review and

Jakrin Kewcharoen1,2, Narut Prasitlumkum1, Chanavuth Kanitsoraphan1

  • 1University of Hawaii Internal Medicine Residency Program, Honolulu, HI, USA.

Insights

Cognitive impairment significantly increases mortality risk in heart failure patients. This meta-analysis confirms a strong association between cognitive decline and worse outcomes in individuals with heart failure, highlighting a critical area for further research.

Area of Science:

  • Cardiology
  • Neurology
  • Public Health

Background:

  • Heart failure (HF) is associated with a higher prevalence of cognitive impairment compared to the general population.
  • The impact of cognitive impairment on cardiovascular outcomes in HF patients remains unclear.
  • This study addresses the need to understand the relationship between cognitive function and mortality in HF.

Purpose of the Study:

  • To systematically review and meta-analyze existing research.
  • To assess the association between cognitive impairment and mortality in heart failure patients.
  • To provide a pooled estimate of the risk of mortality in HF patients with cognitive impairment.

Main Methods:

  • Comprehensive literature search of MEDLINE and EMBASE databases up to October 2018.
  • Inclusion of cohort studies and randomized control trials evaluating cognitive impairment and mortality in HF.
  • Meta-analysis using a random-effects model to calculate pooled hazard ratios (HR) and 95% confidence intervals (CI).

Main Results:

  • Eight studies involving 3318 participants were analyzed.
  • 951 participants had diagnosed cognitive impairment.
  • Cognitive impairment was significantly associated with increased mortality risk in HF patients (pooled HR = 1.64, 95% CI = 1.42-1.88).

Conclusions:

  • Cognitive impairment is a significant predictor of increased mortality in the heart failure population.
  • A strong association exists between cognitive impairment and higher mortality risk in HF.
  • Further research is warranted to elucidate the underlying pathophysiology of this association.
Abstract

Related Concept Videos

Increased pulse rate01:17

Increased pulse rate

Tachycardia is a condition marked by an abnormally fast or irregular heart rate, surpassing the typical resting rate. In adults, tachycardia is characterized by a pulse rate ranging from 100 to 180 beats per minute. The increased heart rate can result in inadequate blood flow to various body parts, ultimately diminishing the oxygen supply to organs and tissues.
Many factors can elevate the risk of developing tachycardia. These include advanced age, a family history of arrhythmias, and an...
1.1K
Heart Failure II: Pathophysiology01:29

Heart Failure II: Pathophysiology

Systolic Heart Failure and Compensatory MechanismsSystolic heart failure (also termed HFrEF, Heart Failure with Reduced Ejection Fraction) is the most prevalent type of heart filure. It results in a decreased volume of blood being pumped from the ventricle. The aortic arch and carotid sinuses have baroreceptors that detect reduced blood pressure, triggering the sympathetic nervous system (SNS) to release epinephrine and norepinephrine. Initially, this response aims to boost heart rate and...
783
Pathophysiology of Heart Failure01:17

Pathophysiology of Heart Failure

Heart failure (HF) is a progressive syndrome involving ventricles that leads to inadequate cardiac output. It can be classified based on location and output or ejection fraction. Ejection fraction (EF) is an essential measurement in the diagnosis and surveillance of HF. Reduced EF corresponds to systolic heart failure (HFrEF). However, HF with preserved ejection fraction (HFpEF) is becoming increasingly prevalent. Also known as diastolic HF, this form of HF is related to aging. The...
3.0K
Heart Failure I: Introduction01:27

Heart Failure I: Introduction

Heart failure refers to a clinical syndrome caused by structural or functional cardiac disorders that prevent the heart from pumping an adequate amount of blood to meet the body's metabolic needs. This condition often arises from myocardial infarction or ischemia, leading to decreased cardiac output, reduced tissue perfusion, impaired gas exchange, fluid volume imbalance, and decreased functional ability.Heart failure can result from disruptions in the mechanisms that regulate cardiac output...
723
Heart Failure VI: Adjunct Therapies01:22

Heart Failure VI: Adjunct Therapies

Additional therapies for treating patients with heart failure (HF) may include procedural interventions, supplemental oxygen, the management of sleep disorders, and nutritional therapy.Procedural InterventionsImplantable Cardioverter-Defibrillator: For patients at risk of life-threatening arrhythmias due to severe left ventricular dysfunction, an Implantable Cardioverter-Defibrillator (ICD) can detect and terminate these arrhythmias, preventing sudden cardiac death and improving survival rates.
277
Heart Failure Drugs: Diuretics01:22

Heart Failure Drugs: Diuretics

Heart failure and kidney perfusion are interconnected in a complex way. Reduced renal perfusion and venous congestion are two significant factors that contribute to renal dysfunction in heart failure. The kidneys, primarily responsible for fluid balance in the body, are adversely affected due to compromised cardiac output and increased venous pressure. In response to reduced renal perfusion, the kidneys activate neurohumoral mechanisms to restore balance. However, these mechanisms can be...
824